Gabrielle Scher

Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus

Colleen Furey, Gabrielle Scher, Naiqing Ye et al. · Nature Communications · 2024 · 66 citations · Full text

Immune history shapes human antibody responses to H5N1 influenza viruses

Tyler A. Garretson, Jiaojiao Liu, Shuk Hang Li et al. · Nature Medicine · 2025 · 28 citations

Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates

Drishya Kurup, Christine R. Fisher, Gabrielle Scher et al. · The Journal of Infectious Diseases · 2021 · 26 citations · Full text

TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype

Rossella Tricarico, Jozef Madžo, Gabrielle Scher et al. · Gastroenterology · 2023 · 26 citations · Full text

Cancer Immunosurveillance, Intestinal Tumorigenesis, T-regulatory Cell +6

GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus

Gabrielle Scher, Dennis A. Bente, Megan C. Mears et al. · npj Vaccines · 2023 · 22 citations · Full text